Korean Red Ginseng Improves Blood Pressure Stability in Patients with Intradialytic Hypotension

Table 2

Comparison of body weights and ultrafiltration rates with and without Korean red ginseng treatment.

	Group A (HTN)		𝑃 value	Group B (non-HTN)		𝑃 value	All		𝑃 value
	Phase I (−KRG)	Phase II (+KRG)		Phase I (−KRG)	Phase II (+KRG)		Phase I (−KRG)	Phase II (+KRG)
BW predialysis (Kg)	65.3±15.5	65.4±15.4	0.862	61.6±18.8	61.7±18.8	0.218	63.4±17.2	63.4±17.1	0.415
BW postdialysis (Kg)	62.7±15.0	62.8±15.0	0.296	59.0±18.1	58.9±18.1	0.888	60.7±16.6	60.7±16.6	0.994
Dry BW (Kg)	62.5±15.0	62.6±15.0	0.054	59.0±18.1	59.0±18.2	0.386	60.7±16.6	60.7±16.6	0.282
Target UF (L)	2.6±1.0	2.6±0.9	0.616	2.7±1.0	2.8±1.1	0.322	2.6±1.0	2.7±1.0	0.33
Actual UF (L)	2.8±1.1	2.7±1.0	0.850	2.7±1.1	3.0±1.6	0.198	2.7±1.1	2.9±1.4	0.338
% target UF	100.0±21.5	106.4±39.1	0.231	103.8±10.4	103.0±10.6	0.794	102.0±16.5	104.6±27.6	0.319

Values are expressed as means ± SD; BW, body weight; KRG, Korean red ginseng; UF, ultrafiltration; % target UF, percentage of actual UF/target UF. Phase I is the controlled phase without KRG treatment, expressed as −KRG; phase II is the KRG treatment phase, expressed as +KRG.